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Abstract 
Introduction: Effective post-operative pain management is one of the problems following 
root canal treatment. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most 
commonly prescribed analgesics in endodontics. The aim of this study was to evaluate the 
effectiveness of naproxen in controlling pain following root canal treatment in teeth with 
irreversible pulpitis. 
Materials and methods: This triple-blinded clinical trial was performed on 68 patients 
admitted to dental school for root canal treatment (RCT). Patients were randomly allocated to 
treatment or placebo groups. After performing RCT, the patients received naproxen (275 mg 
every 12 hours for 48 hours) or placebo. Patients were instructed to complete a VAS pain 
score at 6, 12, 24, 48 and 72 h after single visit root canal treatment. Patients were classified 
as having no, mild, moderate, or severe pain. Data were analyzed via SPSS software using 
chi-square and t-test.    
Results: Although there was a significant difference between naproxen prescription 
compared with placebo in 6 and 72 hour intervals, the effect of naproxen in controlling post 
endodontic pain in all intervals was more than placebo. In addition, the duration of pain was 
shorter in the subjects receiving naproxen.  
Conclusion: Based on the results of the present study, naproxen could be suggested to 
control post endodontic pain in patients with irreversible pulpitis. 
Keywords: Root canal treatment, Postoperative pain, Naproxen, Irreversible pulpitis 
Introduction 
Pain after root canal treatment (RCT) is a 
major concern for both patients and 
clinicians (1). The prevalence of post-
operative pain in different studies is 
estimated to be 10.6 %- 82.9% (2). 
Different factors contribute to the 
development of post-operative pain, 
including: the tooth affected, age, sex, a 
previous experience, psychological factors, 
immunologic factors, unadjusted 
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temporary restoration, microbial factors, 
chemical cytokines, intraoperative factors 
and increased periapical tissue pressure (2-
4). 
A variety of studies have evaluated the 
efficacy of different strategies to control 
post-operative pain in endodontics (3, 5, 
6). Commonly used methods are 
considered administration of long acting 
anesthetics and using analgesic drugs. 
Numerous investigations have 
demonstrated that regular administration 
of analgesics following RCT could reduce 
post-operative pain (7,8). However, 
Parirokh et al. (2014) have shown that 
regular administration of Ibuprofen after 
RCT in patients, who had irreversible 
pulpitis without moderate to severe 
spontaneous pain, had no significant effect 
on pain relief compared with an on-
demand regimen up to 48 hours after 
treatment (9). 
Non-steroidal anti-inflammatory drugs 
(NSAIDs) are the most common agents 
used to control post-operative pain (8). 
They inhibit Cyclo-oxygenase enzyme and 
thus prevent the catalysis of Arachidonic 
acid to prostaglandins, one of the most 
important chemical agents involved in pain 
and inflammation (1). Ibuprofen is the 
drug of choice to reduce pulpal 
inflammation and pain (2, 7). Onset of 
action is longer for Naproxen compared to 
that for Ibuprofen. However, the duration 
of analgesia obtained with Naproxen is 
higher than Ibuprofen (10). 
Due to the fact that maximum pain 
following RCT is observed within the first 
24 hours (11), Naproxen could be a good 
candidate to reduce pain in the patients. 
Furthermore, naproxen has the minimal 
cardiovascular side effects amongst 
NSAID’s (12). Regarding the increasing 
prevalence of cardiovascular diseases; 
naproxen seems to be a good candidate to 
control post-operative pain . 
Wells et al. (2006) determined the efficacy 
of Ibuprofen and ibuprofen/acetaminophen 
on postoperative pain in symptomatic 
patients with a pulpal diagnosis of 
necrosis. There was no statistically 
significant difference between the 2 groups 
for analgesic use or escape medication use. 
(13). Another study compared the effects 
of single doses of Tramadol, Novafen and 
Naproxen on postoperative pain following 
instrumentation of root canals in teeth with 
irreversible pulpitis. All three agents 
reduced post-operative pain, though 
tramadol was significantly less effective 
than naproxen, and novafen that were 
similar to each other (1). In the study by 
Gottesdiener et al. also, naproxen was 
efficacious in the treatment of 
postoperative pain after surgical removal 
of third molars. (14). 
Regarding the noticeable benefits of 
naproxen including few side effects, 
accessibility, relative low price and 
considering the fact that there is no study 
evaluating the efficacy of regularly 
scheduled administration of naproxen on 
endodontic post-operative pain, the aim of 
the current study was to determine the 
analgesic effect of naproxen 
administration following root canal 
treatment of teeth with the diagnosis of 
irreversible pulpitis. 
Materials and methods 
Sixty-eight patients participated in this 
triple-blinded randomized clinical trial that 
was approved by the Ethics Committee of 
Rafsanjan University of Medical Sciences. 
The inclusion criteria included: no 
systemic diseases, no detected sensitivity 
to 2% lidocaine with 1:80,000 epinephrine 
and NSAID’s, having an asymptomatic 
molar with the diagnosis of irreversible 
pulpitis . 
Exclusion criteria of participation in this 
study were: pregnancy, lactation, and 
patients younger that 18 or older than 40 
years of age . 
After explaining the procedure of 
treatment, the written informed consents 
were obtained from the patients. Naproxen 
(275 mg) and placebo tablets were 
provided by Pars Darou Company and 
were matched in size and shape. The 
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packaging of an actual generic analgesic 
drug was used for. Immediately after root 
canal treatment, patients were randomly 
given 12 tablets of either naproxen or 
placebo. Patients, clinician and statistician 
were all blinded to treatment allocation . 
Under local anesthesia with 2% lidocaine 
and 1/80000 epinephrine, an access cavity 
was made. Following isolation with rubber 
dam, cleaning and shaping was performed 
using passive step back technique. 
Irrigation was performed with normal 
saline. Obturation was done using cold 
lateral condensation technique with gutta 
percha (Arya dent, Iran) and ZOE sealer. 
All the cases were treated in a single visit. 
The pain ratings were explained to the 
patients before injection. The patients were 
asked to grade their pain on a Heft-Parker 
Visual Analogue Scale (VAS) with 170-
mm line. The millimeter marks were 
removed from the scale, and the scale was 
divided into 4 categories with various 
terms describing the level of pain: no pain 
corresponded to 0 mm; faint, weak, or 
mild pain corresponded to 1–54 mm; 
moderate pain corresponded to 55–114 
mm; and strong, intense, and maximum 
possible pain corresponded to more than 
114 mm (13). 
The patients were advised to take one 
tablet immediately after treatment, 
followed by another tablet every 6 hours 
for 72 hours. Subjects were also asked to 
record their pain scores at 6, 12, 24, 48 and 
72 hours after treatment. Patients who 
experienced severe pain were excluded 
from the study and received extra 
analgesics . 
Statistical analysis consisted of Student's t 
test and chi-square analysis on a software 
program SPSS (IBM, USA) for Windows 
ver. 16.0. P<0.05 was considered 
statistically significant.  
Results 
Six patients were excluded from the study 
due to incomplete pain record or taking 
extra drugs. Data of 62 patients (32 in 
Naproxen group, 30 in placebo group) 
were analyzed. There were no significant 
differences between the groups in terms of 
demographic variables (age, sex and the 
kind of treated tooth) (p>0.05). 
Table 1 shows the percentage of patients in 
different pain intensity categories. As 
shown in table and figure 1, the 
percentages of patients having a moderate 
or severe pain at all time intervals were 
higher in placebo group than that of 
naproxen-treated subjects. These 
differences were statistically significant at 
6 and 72 hours post-operative intervals (p< 
0.05).
  
 
Table 1. The percentage of patients in different pain intensity categories in naproxen and placebo groups. 
Time post-treatment Group No pain Mild pain Moderate pain Severe pain 
6h Naproxen 36.7 33.3 30 0 
Placebo 15.6 31.3 37.5 15.6 
12h Naproxen 43.3 26.7 26.7 3.3 
Placebo 31.3 25 28.1 15.6 
24h Naproxen 56.7 23.3 16.7 3.3 
Placebo 31.3 34.4 15.6 18.8 
48h Naproxen 66.7 30 3.3 0 
Placebo 46.9 31.3 12.5 9.4 
72h Naproxen 83.3 10 6.7 0 
Placebo 53.1 25 9.4 12.5 
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    Figure 1: Comparison of sever pain between the two groups at 6, 12, 24, 48 and 72 hours post treatment. 
Discussion  
Pain during and subsequent to root canal 
treatment (RCT) may lead to patient 
dissatisfaction with medical service, evoke 
fear of dental treatments and act as a 
barrier to adherence and willingness to 
continue treatment. Hence effective pain 
control is of great importance in 
endodontics (15). In the present study, the 
administration of naproxen postoperatively 
reduced pain for teeth with asymptomatic 
irreversible pulpitis. 
One of the factors contributing to the 
development of pain after RCT is the 
trauma directly applied to the 
periodontium. This event leads to 
membrane degradation of vascular and 
cellular structures and release of some 
inflammatory cytokines including 
prostaglandins (PG), and thromboxanes 
(TX). The formation of each inflammatory 
cytokines is associated with pain after 
RCT procedure (16, 17). Naproxen is a 
nonselective COX-1 and COX-2 inhibitor 
and therefore exerts its analgesic effect 
through peripheral inhibition of the 
production of PG’s and TX’s (1). 
In a study by Sanders et al. on patients 
with hand pain in osteoarthritis, significant 
reductions in brain activity following 
treatment with naproxen, compared to 
placebo, were observed in brain regions 
commonly associated with pain 
perception, including the bilateral primary 
somatosensory cortex, thalamus, and 
amygdala. Significant relationships 
between changes in perceived pain 
intensity and changes in brain activity 
were also observed in brain regions 
previously associated with pain intensity 
(18). Hence it seems rationale to observe 
pain reduction following administration of 
naproxen immediately after RCT . 
In the current research, Pain levels were 
evaluated within the first 72 hours after 
RCT. This time window was selected 
based on the fact that the maximum pain 
intensity is experienced within the first 24 
hours and pain usually subsides within 72 
hours (11). 
None of the patients reported adverse 
effects associated with the use of 
Naproxen. This is in part due to the fact 
that the patients didn't have prior systemic 
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disease. Moreover, this trial was limited by 
the short duration of drug administration. 
However, long-term use of naproxen has 
been associated with increased incidence 
of gastrointestinal side-effects (19). 
The analgesic efficacy of placebo was 
significantly lower than that of naproxen 
in 6 and 72 hours post-treatment. A larger 
sample size and higher doses of naproxen 
may lead to more significant differences 
between the two groups. However, in 
accordance with previous studies we 
propose that placebo analgesia, including 
physiological phenomena, is a facet of 
pain perception (20, 21). 
Polat et al. (2005) evaluated the effects of 
preoperative ibuprofen and naproxen 
sodium on orthodontic pain. The results 
revealed that patients taking 550 mg 
naproxen sodium one hour before archwire 
placement had significantly lower levels of 
pain at two hours, six hours, and nighttime 
after adjustment than patients taking 
placebo or ibuprofen (22).  In another 
study, there was no significant difference 
between rofecoxib and naproxen in 
controlling post-surgical dental pain (23). 
In the study by Bjørnsson et al., naproxen 
was superior to acetaminophen at 8, 12, 
and 16 hours on the 1st postoperative day 
and at 8 hours on the 2nd postoperative 
day, when the pain intensity was lower 
than that on the first day of third molar 
surgery (24). Moreover, similar to our 
study, Mehrvarzfar et al. found that 
naproxen taken immediately after 
treatment reduced postoperative pain 
following pulpectomy and root canal 
preparation of teeth with irreversible 
pulpitis. However, they used a single oral 
dose of the analgesics (1). 
The maximum postoperative endodontic 
pain level experienced by patients has 
been reported within the first two to 10 
hours (25). Saberi et al. also have shown 
that maximum pain intensity is recorded 
within six hours after RCT (26). In the 
current study, naproxen showed a 
significant reduction in postoperative pain 
level within the first 6 hours, in 
comparison with placebo. This finding 
may lead the clinicians to consider 
naproxen as a good analgesic after RCT. 
The usual dosage range for commonly 
used naproxen in different studies has been 
275- 550 mg (24). To minimize the side 
effects, we used the minimum dosage 
recommended by previous studies, though 
increasing the dose of naproxen would 
improve analgesic efficacy. However, 
future studies should attempt to evaluate 
different dose. 
The presence of pre-treatment pain 
increases the chances for more severe 
postoperative pain (27). Considering this 
fact and because of the use of placebo in 
the current study, asymptomatic teeth with 
irreversible pulpitis were included in the 
present survey. 
2% lidocaine with epinephrine 1/80,000 is 
one of the most frequently used anesthesia 
in endodontics. So, we used this form of 
analgesic agent in our study. 
Conclusion  
According to the results of the present 
study, administration of naproxen after 
treatment reduced postoperative pain 
following root canal therapy. On the other 
hand, naproxen has the minimal 
cardiovascular side effects amongst 
NSAID’s. Therefore, we recommend the 
prescription of naproxen as an analgesic 
after RCT, especially, in patients with 
cardiovascular problems. However, future 
studies with larger sample size and 
improved designs are necessary to 
illustrate the efficacy of naproxen on post-
operative pain in endodontics. 
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